The level of science required to back health claims under Europe’s new regulations is high, and negative opinions are likely, but there is no need to panic, says Indena’s Christian Artaria. Yet.
It’s been a good week for Norwegian supplier, NattoPharma, which has had its application for the safe addition of vitamin K2 (menaquonine) to various foods and food supplements accepted by the European Food Safety Authority (EFSA) and won a Frost &...
At HIE in Paris, NutraIngredients gained an exclusive interview with EFSA's chief health claim assessor, Professor Albert Flynn. EFSA has copped a lot of flak for its gold standard scientific approach, but Professor Flynn said his agency would not...
The World Health Organization’s food supplements regulation guideline body, Codex, has broadened its definition of what can be considered worthy scientific evidence to back health claims.
A daily supplement of B vitamins may reduce the risk of breast cancer and other invasive cancers in women over the age of 65, according to a new study from the US.
The European Food Safety Authority (EFSA) will not moderate its ‘gold standard’ approach to health claims and should not be criticised for doing so, according to the chair of its claims assessment panel.
Benecol has joined its main competitor, Unilever-owned plant sterol-based, functional food range, Flora pro.activ, in having a cholesterol-lowering health claim approved by the European Food Safety Authority (EFSA).
Danish-based supplier and supplements maker, New Nordic, has been rapped over bone health and arterial claims it has been making for vitamin K2 food supplements in the UK.
The latest batch of European Food Safety Authority (EFSA) opinions has surfaced with the assessor giving the thumbs up to three claims revolving around calcium, vitamin D and bone health.
The UK’s Advertising Standards Agency has upheld complaints against two ‘misleading and inaccurate’ adverts for Nestle’s Maggi Noodles and GlaxoSmithKline’s Horlicks which made unsubstantiated health claims.
The European Food Safety Authority’s hard line stance on health claims is bewildering some, resigning others, but steeling most to meet its ‘gold standard’ scientific demands.
Martek Biosciences Corporation is disappointed but not devastated by the European Food Safety Authority’s rejection of its article 14 DHA/ARA infant nutrition health claim.
The European Food Safety Authority recently turned in its first health claim verdicts, rejecting eight of nine. European food regulations expert Lorène Courrège explains why EFSA’s tough health claim approach may stifle product innovation.
The European Food Safety Authority (EFSA) has rejected a Martek Biosciences Corporation health claim submission relating infant brain and eye development with DHA (omega-3) and ARA (omega-6) consumption.
Imperfect as they may be, the European Union’s regulatory efforts in the food area have attracted the attention of regulators around the world, some of whom view what is being done in the bloc as a legislative template.
